1. Home
  2. PTHL vs BNC Comparison

PTHL vs BNC Comparison

Compare PTHL & BNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • BNC
  • Stock Information
  • Founded
  • PTHL 1998
  • BNC N/A
  • Country
  • PTHL China
  • BNC United States
  • Employees
  • PTHL N/A
  • BNC N/A
  • Industry
  • PTHL
  • BNC Industrial Machinery/Components
  • Sector
  • PTHL
  • BNC Industrials
  • Exchange
  • PTHL Nasdaq
  • BNC Nasdaq
  • Market Cap
  • PTHL 13.5M
  • BNC 13.7M
  • IPO Year
  • PTHL 2024
  • BNC N/A
  • Fundamental
  • Price
  • PTHL $1.02
  • BNC $20.50
  • Analyst Decision
  • PTHL
  • BNC
  • Analyst Count
  • PTHL 0
  • BNC 0
  • Target Price
  • PTHL N/A
  • BNC N/A
  • AVG Volume (30 Days)
  • PTHL 1.9M
  • BNC 363.0K
  • Earning Date
  • PTHL 01-01-0001
  • BNC 09-16-2025
  • Dividend Yield
  • PTHL N/A
  • BNC N/A
  • EPS Growth
  • PTHL N/A
  • BNC N/A
  • EPS
  • PTHL N/A
  • BNC N/A
  • Revenue
  • PTHL $448,196.00
  • BNC $3,478,254.00
  • Revenue This Year
  • PTHL N/A
  • BNC N/A
  • Revenue Next Year
  • PTHL N/A
  • BNC N/A
  • P/E Ratio
  • PTHL N/A
  • BNC N/A
  • Revenue Growth
  • PTHL N/A
  • BNC 10.08
  • 52 Week Low
  • PTHL $0.51
  • BNC $5.60
  • 52 Week High
  • PTHL $32.00
  • BNC $82.88
  • Technical
  • Relative Strength Index (RSI)
  • PTHL 30.37
  • BNC N/A
  • Support Level
  • PTHL $0.70
  • BNC N/A
  • Resistance Level
  • PTHL $1.18
  • BNC N/A
  • Average True Range (ATR)
  • PTHL 0.15
  • BNC 0.00
  • MACD
  • PTHL 0.68
  • BNC 0.00
  • Stochastic Oscillator
  • PTHL 76.30
  • BNC 0.00

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: